Aniracetam vs Selank for anxiety
Short answer: For anxiety, more users report improvement with Selank — 97% of 112 reports, versus 92% of 191 for Aniracetam.
Aniracetam has 1 meta-analyses and 9 randomized trials on PubMed; Selank has 0 and 2.
Based on 899 reports about Aniracetam and 383 about Selank. Not medical advice.
| Aniracetam Supplement | Selank Peptide | |
|---|---|---|
| Users say it helped | 60%helped405 reports · high confidence | 75%helped138 reports · high confidence |
| Verdict | Mostly positive | Mostly positive |
| Research | BResearch: Moderate | CResearch: Limited |
| Meta-analyses / RCTs | 1 / 9 | 0 / 2 |
| Mainly used for | ||
| Anxiety % reporting improvement | 92% (191) | 97% (112) |
| Focus % reporting improvement | 85% (200) | 86% (36) |
| Mood % reporting improvement | 87% (100) | 90% (39) |
| Memory % reporting improvement | 85% (55) | 100% (9) |
| Energy % reporting improvement | 64% (22) | 100% (4) |
| Common side effects | drowsiness, irritability, fatigue, headache | headache, tolerance, injection site, tingling |
| Typical dose reported | 750 mg | Not listed |
The most effective intervention for dementia available is symptomatic treatment for vascular dementia. Antipsychotic treatment for dementia alleviates cognitive dysfunction less effectively than does symptomatic treatment. Alternative therapies are also effective at present. Further research on causes and very early diagnosis of Alzheimer disease is warranted.
Psychopharmacology (Berl), 2018 ↗“Aniracetam: Anecdotally I could feel instantaneous mental improvement within 2-3 days... The most significant improvement was attention... organization, and confidence.”
“Selank has improved my anxiety immensely, and am able to focus on things clearly.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate